期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 99, 期 4, 页码 2185-2195出版社
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21978
关键词
emodin; omega-hydroxyemodin; pharmacokinetics; metabolism; glucuronides
资金
- National Science Council, ROC [NSC95-2320-B039-023-MY2, NSC 96-2320-B-039-037-MY3]
- Committee on Chinese Medicine and Pharmacy, ROC [CCMP93-RD-006, CCMP95-TP-027]
- China Medical University, ROC [CMU95-082, CMU95-225]
Emodin, a natural anthraquinone polyphenol, has been reported to possess promising in vitro antioxidation, anticancer and anti-inflammatory activities. Whether the in vitro bioactivities can predict in vivo effects remained an unanswered question without understanding emodin pharmacokinetics in animals. To fill this blank, this study investigated the biological fate of emodin in rats. Emodin was intravenously (5.0 mg/kg) and orally (20.0 and 40.0 mg/kg) administered to rats. Blood samples were assayed by HPLC before and after hydrolysis with sulfatase and p-glucuronidase. It is observed that after intravenous bolus of emodin, the parent form of emodin declined rapidly, and emodin glucuronides, omega-hydroxyemodin (omega-OHE) and omega-OHE sulfates/glucuronides all emerged instantaneously. In contrast, when emodin was given orally, emodin glucuronides were exclusively present in serum, whereas emodin, omega-OHE and omega-OHE sulfates/glucuronides were not detected. In order to evaluate the in vivo antioxidation activity, the serum metabolites of emodin following intravenous and oral administrations were prepared from rats and characterized, followed by investigating the effects on 2,2'-azobis(2-amidinopropane hydrochloride)-induced hemolysis. The results suggested that the serum metabolites of oral emodin exhibited more promising free radical scavenging activity than those of intravenous emodin and emodin parent form. We suggest biologists to redirect their targets to emodin glucuronide. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:2185-2195, 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据